Bønes, Norway

James Bradley Lorens

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Bønes, NO (2007 - 2023)
  • Bones, NO (2008 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James Bradley Lorens

Introduction

James Bradley Lorens, based in Bønes, Norway, is a noteworthy inventor with a substantial portfolio consisting of 14 patents. His work primarily focuses on advancements in biotechnology, particularly concerning antibodies and their applications.

Latest Patents

Among his notable inventions are the patented Anti-Axl antagonistic antibodies. This technology pertains to antibodies that specifically bind to a novel epitope on the Axl protein, contributing significantly to the field of targeted therapies. Another invention revolves around the same anti-Axl antagonistic antibodies, which inhibit the interaction between Axl and its ligand, Gas6. Not only do these patents highlight Lorens' scientific ingenuity, but they also showcase methods for the production and application of these critical antibodies.

Career Highlights

Throughout his career, Lorens has made significant strides in the pharmaceutical industry, having worked with reputable organizations such as Rigel Pharmaceuticals and Bergenbio ASA. His contributions have paved the way for innovative therapeutic solutions, particularly in oncology and autoimmune diseases.

Collaborations

Collaboration has been vital to Lorens' success, particularly working alongside esteemed colleagues such as David Robert Micklem and Sacha Holland. These partnerships have enabled him to expand his research and innovate further in the field of biotechnology.

Conclusion

James Bradley Lorens is a prominent inventor whose work in antibody research continues to impact the scientific community. With numerous patents and valuable collaborations, he remains a significant figure in advancing therapeutic innovations that address critical health issues. His ongoing contributions will likely inspire future advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…